Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes.
Watson DC, Moysi E, Valentin A, Bergamaschi C, Devasundaram S, Fortis SP, Bear J, Chertova E, Bess J Jr, Sowder R, Venzon DJ, Deleage C, Estes JD, Lifson JD, Petrovas C, Felber BK, Pavlakis GN. Watson DC, et al. Among authors: fortis sp. PLoS Pathog. 2018 Feb 23;14(2):e1006902. doi: 10.1371/journal.ppat.1006902. eCollection 2018 Feb. PLoS Pathog. 2018. PMID: 29474450 Free PMC article.
Correction: Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes.
Watson DC, Moysi E, Valentin A, Bergamaschi C, Devasundaram S, Fortis SP, Bear J, Chertova E, Bess J Jr, Sowder R, Venzon DJ, Deleage C, Estes JD, Lifson JD, Petrovas C, Felber BK, Pavlakis GN. Watson DC, et al. Among authors: fortis sp. PLoS Pathog. 2018 Oct 11;14(10):e1007345. doi: 10.1371/journal.ppat.1007345. eCollection 2018 Oct. PLoS Pathog. 2018. PMID: 30308061 Free PMC article.
Red Blood Cell Abnormalities as the Mirror of SARS-CoV-2 Disease Severity: A Pilot Study.
Bouchla A, Kriebardis AG, Georgatzakou HT, Fortis SP, Thomopoulos TP, Lekkakou L, Markakis K, Gkotzias D, Panagiotou A, Papageorgiou EG, Pouliakis A, Stamoulis KE, Papageorgiou SG, Pappa V, Valsami S. Bouchla A, et al. Among authors: fortis sp. Front Physiol. 2022 Jan 20;12:825055. doi: 10.3389/fphys.2021.825055. eCollection 2021. Front Physiol. 2022. PMID: 35126186 Free PMC article.
Economic crisis in Greece: The invisible enemy of blood donation or not?
Fortis SP, Kriebardis AG, Georgatzakou HT, Lyrakos G, Alexiou P, Antoniou C, Papadopoulos G, Stamoulis KE, Valsami S. Fortis SP, et al. Transfus Apher Sci. 2022 Dec;61(6):103467. doi: 10.1016/j.transci.2022.103467. Epub 2022 May 21. Transfus Apher Sci. 2022. PMID: 35623957
Blood Cell-Derived Microvesicles in Hematological Diseases and beyond.
Georgatzakou HT, Fortis SP, Papageorgiou EG, Antonelou MH, Kriebardis AG. Georgatzakou HT, et al. Among authors: fortis sp. Biomolecules. 2022 Jun 8;12(6):803. doi: 10.3390/biom12060803. Biomolecules. 2022. PMID: 35740926 Free PMC article. Review.
Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics.
Fortis SP, Vaxevanis CK, Mahaira LG, Sofopoulos M, Sotiriadou NN, Dinou A, Arnogiannaki N, Stavropoulos-Giokas C, Thanos D, Baxevanis CN, Perez SA. Fortis SP, et al. Cancer Immunol Immunother. 2019 Jan;68(1):57-70. doi: 10.1007/s00262-018-2252-7. Epub 2018 Oct 1. Cancer Immunol Immunother. 2019. PMID: 30276443 Free PMC article.
45 results